Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
|Articles|January 11, 2022
Daily OTC Pearl: Royal Jelly Propolis
Author(s)Saro Arakelians, PharmD
Royal Jelly is rich in proteins, fatty acids, vitamins, minerals, enzymes, carotenoids, and bioflavonoids.
Advertisement
OTC/Lifestyle Pearl of the Day: Royal Jelly Propolis
Indication: Royal Jelly is used both orally and topically to support wound healing and other inflammatory skin conditions.
Insight:
- Chewable tablet is a natural mixture of propolis, royal jelly, and pollen, and is the best way to consume natural bee products daily with its unique taste.
- It is rich in proteins, fatty acids, vitamins, minerals, enzymes, carotenoids, and bioflavonoids.
- Ingredients: Bee pollen (30%), propolis (18%), bee pollen (12%), carob, and cocoa.
- Take 2 tablets 1 or 2 times a day or more as needed, preferably between meals.
- Royal Jelly is known to have an antibacterial effect, which can keep wounds clean and free from infection.
- Unsuitable for infants under 1 year old. Do not buy if the security seal is torn.
- One animal study revealed an increase in collagen production in rats given royal jelly extract.
- A test tube study showed significantly enhanced tissue repair capacity in human cells treated with royal jelly.
Sources:
Advertisement
Related to this article
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
Advertisement
Advertisement
Trending on Pharmacy Times
1
From Recognition to Prior Authorization: ATTR-CM Diagnosis Gaps
2
Earlier PRRT in Neuroendocrine Tumors Puts Pharmacists at the Center of Coordination
3
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
4
FDA Approves Perioperative Durvalumab Plus Enfortumab Vedotin-ejfv for MIBC
5